• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Baxter’s Artiss sealant wins FDA clearance for face-lift procedures | Regulatory Roundup

Baxter’s Artiss sealant wins FDA clearance for face-lift procedures | Regulatory Roundup

September 6, 2011 By MassDevice staff

Baxter

Baxter International Inc. (NYSE: BAX) won an expanded indication for its Artiss fibrin sealant, making it available for use during in sealing tissue flaps during face-lift surgeries.

Artiss first won FDA clearance in 2008 for use in adhering skin grafts in wound beds prepared for treating burns in adults and children over the age of one.

Sign up to get our free newsletters delivered right to your inbox.

The sealant is also approved for use in burn, reconstructive and plastic surgeries in 15 European countries, according to a press release.

"In traditional face-lift procedures, sutures are used to close the flap of skin at its edge, often leaving a space underneath the tissue that can lead to post-operative complications," according to the release. "Artiss sets within 60 seconds, giving surgeons time to manipulate and accurately position the skin flap. Artiss contains blood plasma proteins essential to clot formation."

The Deerfield, Ill.-based company recently posted double-digit growth for its second quarter ended June 30, amounting to $629 million in earnings on sales of $3.5 billion, representing an 11 percent increase in sales and a 17 percent increase in profits over the second quarter of 2010.

Regulatory Roundup

  • LED Dental wins CE Mark for screening device
    LED Dental Inc. landed CE Mark approval in the European Union for its flagship Velscope Vx oral screening device for locating and identifying abnormal tissue that may not be visible to the naked eye. Clinical studies showed that including the Velscope device during a traditional head and neck exam helped locate lesions, including cases of dysplasia, that were missed when not using the device.
    Read more
  • Cellvizio 100 laser system wins FDA clearance
    Paris-based Mauna Kea Technologies ( EPA:MKEA) announced FDA clearance for its next-gen Cellvizio 100 endomicroscopy system for the GI and pulmonary tracts. The system, which won CE Mark in April 2011, provides physicians with real-time microscopic images of tissue inside the body.
    Read more
  • Abbott wins CE Mark for cataract surgery protective gel
    Santa Ana, Calif.-based Abbott Laboratories (NYSE:ABT) won European approval for its Healon EndoCoat ophthalmic viscosurgical device, intended for use as a surgical aid in cataract extraction, intraocular lens (IOL) implantation, corneal transplantation, and glaucoma filtration surgery.
    Read more
  • Hemosphere touts CE Mark for Hero graft
    Eden Prairie, Minn.-based Hemosphere Inc. won CE Mark for its Hero vascular access graft for hemodialysis patients. The device is clinically proven to reduce infections by 69 percent compared to hemodialysis catheters in clinical studies.
    Read more

Filed Under: Cosmetic/Aesthetic, Dental, News Well Tagged With: Abbott, Baxter, Hemosphere Inc., Laser/Light-based Devices, LED Dental Inc., Mauna Kea Technologies

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy